by Callen | Jun 30, 2025 | 101, News
At The Project, our ultimate goal is clear: achieve viral suppression for every person we serve and eliminate new HIV transmissions. Every program we run—every screening, every risk assessment, every health conversation—feeds into that mission.Here’s a quick look at...
by Callen | Dec 1, 2024 | 101, News, Treatment & Care
What to Expect at Your First HIV Care Visit Starting HIV care is an important step in managing your health and living well with HIV. At The Project at Primary Health Care, we’re here to make your first visit as comfortable and informative as possible. Here’s what you...
by Callen | Oct 29, 2024 | News
In the last two decades, cases of infectious syphilis in the U.S. have increased by 800%, from 2 to 18 cases per 100,000 people. In Iowa, rates have risen 268% in the last five years, including a 796% increase among females and a 333% rise in cases of congenital...
by Callen | Jul 16, 2024 | News, Videos
At the end of June 2024, Deputy Assistant Secretary of Infectious Disease and Director of the Office of Infectious Disease and HIV/AIDS Policy Kaye Hayes spoke with Francisco Ruiz, the Director of the White House Office of National AIDS Policy (ONAP). The new ONAP...
by Callen | Aug 16, 2023 | News
It’s important to track how well we’re preventing and treating HIV. One measure is how many people with HIV have achieved viral suppression each year. When the virus is controlled, it can’t be passed to others – a concept known as Undetectable...
by Callen | Jun 13, 2023 | Announcements, Care & Prevention, News
In 2022, the FDA approved a new form of PrEP, called injectable cabotegravir (brand name Apretude). Apretude is a single, long-acting injection that is given every two months. It is highly effective at preventing HIV infection, just like oral PrEP. Apretude may be a...
